Cornea

The IOL launch is the company’s second market debut in less than 12 months.

What axial length readings and crystalline lens power tell you.

Pterygium is an ocular disease commonly referred to as “surfer’s eye,” which can result from exposure to high levels of UV radiation.

Before the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment.

The study authors also noted that patients responding well to routine intense pulsed light sessions do not need to undergo additional sessions.

The 1-time, intracameral injection is a cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction.

Shifting the treatment paradigm can lead to less pain, inflammation

Dr Brianna Rhue, OD, FAAO, FSLS details her upcoming presentation "Cutting Out Surgery for the Management of Refractive Error," where she will detail the underutilization of orthokeratology during Vision Expo East 2024 later this week.

Ferroptosis is a form of cell death that depends on the presence of iron in the cells.

Barry Eiden, OD, FAAO, FSLS, sits down with Optometry Times to highlight the importance of staying up-to-date with technology in the development of treatment and diagnosis of keratoconus and what's to come at this year's IKA Keratoconus Symposium in May.

Oluwatosin U Smith, MD, urges consideration of the interaction between corneal and glaucomatous disease whenever treating glaucoma or corneal issues during the annual Glaucoma 360 meeting in San Francisco, California.

OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.

The study, based out of India, successfully transplanted 32 of 34 corneas harvested from drowning victims.

Much has changed in the study of keratoconus over the years.

Damon Dierker, OD, FAAO, shares latest updates in research on sutureless cryopreserved amniotic membrane for moderate-to-severe dry eye with short treatment duration.

Earlier this year, Aurion’s cell therapy received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency for the management of bullous keratopathy, marking the first regulatory approval in the world for an allogeneic cell therapy to manage corneal endothelial disease.

Hear how the Clek study continues to play a role in today's keratoconus care.

Private practice eye care providers’ ability to immediately administer antibiotic eye drops or have them overnighted to the patient is a giant step forward for practice and patient.

The ‘all-in-one’ platform combines specialized imaging and three new FDA-approved apps with a focus on metrics, corneal imaging, and cataract care.

Justin Schweitzer, OD, FAAO, discusses his talk, "Current trends in keratoconus management," at Vision Expo West 2023 in Las Vegas, Nevada.

Combination therapy may reduce adverse events related to corticosteroids alone.

In this part 2 of the pediatric myopia and keratoconus series, Drs Chan and Swartz dive into ortho-k and crosslinking in children.

Treatment requires a systematic, multifaceted approach to improve outcomes.

This NDA transfer marks the fourth FDA-approved ophthalmic product purchased by Harrow earlier in 2023 now commercially available in the US.

A recent study demonstrates the safety and efficacy of treating eyes with cross-linking after keratoconus relapses following keratoplasty.

The use of topical insulin eye drops led to a successful resolution of PEDs in 9 of 11 cases in the study.

At NOA 2023 in Fort Lauderdale, Florida, Rhea Magee, OD, presented a pediatric patient case as part of the Resident Grand Rounds.

Jacobi Cleaver, OD, FAAO, caught up with Optometry Times to talk about his presentation on neurotrophic keratits, which he discussed at the National Optometric Association in Fort Lauderdale, Florida.

Pierce Kenworthy, OD, gives the crowd at NOA 2023 an in-depth look at the cornea and all the dangers that could befall it. He details what clinicians should look for and when to refer to an ophthalmologist for surgery.